rectal cancer

Research in Review
Noncompliance With NCCN Guidelines Can Worsen Rectal Cancer Survival
08/31/2016
JCP Editors
Not complying with recommendations found in National Comprehensive Cancer Network (NCCN) guidelines for locally advanced rectal cancer may led to worse overall survival, according to a study published in the journal...
Not complying with recommendations found in National Comprehensive Cancer Network (NCCN) guidelines for locally advanced rectal cancer may led to worse overall survival, according to a study published in the journal...
Not...
08/31/2016
Journal of Clinical Pathways
Research in Review
Rectal Cancer Treatment Utilizing Chemotherapy and Radiation Therapy Improving Over Time
06/20/2016
JCP Editors
A review of the last decade of care for rectal cancer has found evidence of significant progress in improving patient outcomes despite a number of challenges. For their review, researchers led by Nader N...
A review of the last decade of care for rectal cancer has found evidence of significant progress in improving patient outcomes despite a number of challenges. For their review, researchers led by Nader N...
...
06/20/2016
Journal of Clinical Pathways
Research in Review
Standard Therapy Only Used in Half of US Patients With Rectal Cancer
04/20/2016
JCP Editors
Despite being widely accepted as the standard of care for locally advanced rectal cancer, neoadjuvant chemoradiation (NACRT) is only used in about half of US patients with the disease, according to a recent...
Despite being widely accepted as the standard of care for locally advanced rectal cancer, neoadjuvant chemoradiation (NACRT) is only used in about half of US patients with the disease, according to a recent...
...
04/20/2016
Journal of Clinical Pathways
Research in Review
Non-Operative Management for Rectal Cancer on the Rise Despite Lack of Evidence
04/04/2016
JCP Editors
The use of neoadjuvant chemoradiation for stage 2 and 3 rectal cancer is on the rise, but researchers are unsure whether this represents treatment innovation or greater disparity in cancer care. Currently, the...
The use of neoadjuvant chemoradiation for stage 2 and 3 rectal cancer is on the rise, but researchers are unsure whether this represents treatment innovation or greater disparity in cancer care. Currently, the...
The...
04/04/2016
Journal of Clinical Pathways
Shorter Radiation Courses Safer and Equally Effective for Rectal Cancer Patients
01/19/2016
JCP Editors
Shorter radiation courses followed by consolidation chemotherapy before surgery may be an effective treatment option for rectal cancer patients. High volume bouts of chemoradiation are often used before surgery in...
Shorter radiation courses followed by consolidation chemotherapy before surgery may be an effective treatment option for rectal cancer patients. High volume bouts of chemoradiation are often used before surgery in...
...
01/19/2016
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use